Treatment transmits vibration through the skin, activates cells and stimulates the healing process… Accelerated wound healing yields particular benefits in diabetes patients who suffer from skin ulcers. Faster wound healing also reduces the chances of getting infected, thus lowering amputation incidence and mortality rate. According to Dr. Mark Bass, from …

Patiromer can normalize moderate hyperkalemia, lower potassium levels in as little as 4 weeks…

Study finds diabetes drug does not prevent macrosomia when given to obese women during pregnancy…. Maternal obesity increases the risk of higher infant birth weights as well as complications such as preeclampsia, cesarean section delivery, maternal hemorrhage, infant mortality and stillbirth. Additionally, infants born with higher fat mass are at …

Zosano Pharma is making progress with a patch-based glucagon delivery system for severe hypoglycemia, recently announcing that it has completed enrollment for a phase 2 trial. The idea is to deliver glucagon through a coin-sized patch (about the size of a U.S. quarter). Early studies suggest the microneedle delivery can …

If you get diabetes when you are 60 years old, the odds of developing kidney disease in your lifetime is low. However, if you are diagnosed when you are in your 30s or 40s, the risk is increased, and the likelihood of needing dialysis is greatly increased. This week, we …

This week we have the second part of our two-art interview with Dr. Janice Smiell, CMO at Alliqua BioMedical, Inc. Dr. Smiell, and we delve a little deeper into the specifics of this new technology to heal chronic wounds using placental biomaterials. Steve Freed: With all the testing that is …

The drug reps for DPP-4 inhibitors, GLP-1 agonists, and various insulins have been having a field day talking to prescribers about the possible cardiovascular effects of SGLT-2 inhibitors. This along with the relatively small risk of UTI’s has possibly caused some of our readers to shy away from the whole …

In this week’s Homerun Slides, we continue our short series on introducing SGLT-2 inhibitor therapy to your patients. Topics this week include: Logic for SGLT-2 Inhibition, But Won’t Sugar Hurt My Kidneys, and CV Risk factor Changes with SGLT-2 Inhibitors…

Researchers at McGill University Health Centre, Montreal, Canada, report that metformin has some biochemical properties effects that would suggest a benefit in treating chronic liver diseases. They searched the PubMed and Ovid MEDLINE databases from 2000 to March 2015, but were unable to find any evidence pointing to an independent …

In a 12-year study with over 50 generations, rats who had undernourished ancestors were found to be more susceptible to diabetes and other metabolic diseases… The middle classes from developing countries are more susceptible than western Caucasians to obesity, type 2 diabetes and cardiovascular disease in today’s changing environment. New …